| Literature DB >> 18510727 |
Bjørg Ulvik1, Ottar Nygård, Berit R Hanestad, Tore Wentzel-Larsen, Astrid K Wahl.
Abstract
BACKGROUND: In patients with suspected coronary artery disease (CAD), the overall aim was to analyse the relationships between disease severity and both mental and physical dimensions of health related quality of life (HRQOL) using a modified version of the Wilson and Cleary model.Entities:
Mesh:
Year: 2008 PMID: 18510727 PMCID: PMC2414820 DOI: 10.1186/1477-7525-6-38
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Figure 1A modified version of the Wilson & Cleary model. LVEF: Left ventricular ejection fraction; AFS: Angina Frequency Scale; CCS: Canadian Cardiovascular Society classification; NYHA: New York Heart Association; HADS: Hospital Anxiety and Depression Scale; ECS: Exertional Capacity Scale; SF: Social Function; Coping: Confrontive coping, Normalising Optimistic Coping, Combined Emotive coping; Burden: Perception of living with angina pectoris.
Regression analyses at levels 3–6, sensitivity analysis using alternative definitions withthe cross-loadings of coping scales.
| CAD e | -0.09 | -0.01 | 0.10 | 0.16 | 1.73 | 0.07 |
| AFS f | -0.03 | -0.05 | -0.02 | 0.02; *** | 0.03 | -0.00 |
| HADS-A g | 1.19; *** | 0.80; ** | 1.57; *** | -0.07; *** | -0.54;° | 0.07; *** |
| HADS-D h | -0.43 | -1.39; *** | 0.69; ** | 0.00 | -0.70; * | 0.06; *** |
| CCS i | *** | |||||
| I vs. 0 | 0.65 | 0.63 | 1.33 | -0.34; * | -1.91 | -0.21 |
| II vs. 0 | -0.75 | 0.23 | 2.24 | -0.53; *** | -2.62 | -0.21;° |
| III vs. 0 | -0.31 | 2.50 | 3.03 | -0.49; ** | -1.39 | -0.24 |
| NYHA j | ||||||
| II vs. 0–I | -0.62 | 1.31 | 0.07 | 0.16 | -1.62 | 0.08 |
| III-IV vs. 0–I | -3.02 | -3.14 | 1.22 | 0.15 | -4.44;° | 0.02 |
| ECSk | -0.06 | -0.11; * | -0,06 | 0.02; *** | 0.23; *** | 0.00 |
| SFl | -0.04 | -0.01 | -0.10; *** | 0.00;° | 0.10; ** | -0.01; *** |
| Coa | 0.01; ** | 0.11; * | -0.01; * | |||
| Noa | -0.00 | -0.01 | -0.00 | |||
| Cea | -0.01; *** | -0.19; ** | 0.00 | |||
| Burdenm | *** | |||||
| 5 vs. 6 | -1.38 | -0.28 | ||||
| 4 vs. 6 | -0.39 | -0.51; ** | ||||
| 3 vs. 6 | 0.15 | -0.53; ** | ||||
| 2 vs. 6 | 2.01 | -0.64; ** | ||||
| 1 vs. 6 | 2.20 | -1.12; *** | ||||
| Adjusted R2 | 0.13 | 0.09 | 0.45 | 0.48 | 0.40 | 0.43 |
| Interactions t | 0.34 | 0.76 | 0.33 | 0.25 | 0.21 | 0.29 |
q CAD: Coronary artery disease vs no CAD (after angiography)
a AFS: Angina Frequency Scale (Seattle Angina Questionnaire), scale score 0 (worst) to 100 (best).
b HADS-A: Anxiety (Hospital Anxiety and Depression Scale), scale score 0 (best) to 21 (worst).
c HADS-D: Depression (Hospital Anxiety and Depression Scale), scale score 0 (best) to 21 (worst).
d ECS: Exertional Capacity Scale (Seattle Angina Questionnaire), scale scores 0 (worst) to 100 (best).
e SF: Social Function (SF-36), scale scores 0 (worst) to 100 (best).
f Co: Confrontive coping, No: Normalising Optimistic and Ce: Combined Emotive coping. The three dimensions in Wahl et al's model [33] of the Jalowiec Coping Scale [32]
g Burden: Perceived Burden- perception of living with angina pectoris, 1 (worst) to 6 (best).
h GH: General Health (SF-36), scale scores 0 (worst) to 100 (best).
i QOL: Overall quality of life, 1 (best) to 7 (worst).
t All two-way interactions, overall p-value, feasible after a few simplifications if necessary.
°p ≤ 0.10; * p ≤ .05. ** p ≤ .01. *** p ≤ .001
Demographic and clinical characteristics of study population
| Age | 61.7 (10.2) | ||
| Gender | |||
| Women | 26 | ||
| Men | 74 | ||
| Living alone | 723 | 16 | |
| Education | 718 | ||
| Primary school | 47 | ||
| High school | 33 | ||
| >12 years/college/university | 21 | ||
| Smoking | 735 | ||
| No-smoker | 33 | ||
| Ex-smoker | 45 | ||
| Current smoker | 22 | ||
| Non-cardiac diseases/other health complaints | 538 | 89 | |
| Diabetes Type I or II | 751 | 10 | |
| Body mass index (BMI) kg/m2 | 751 | 26.8 (4.2) | |
| CCS classification of angina a | 752 | ||
| Class 0 (no angina) | 19 | ||
| Class I | 13 | ||
| Class II | 51 | ||
| Class III | 18 | ||
| NYHA classification of dyspnea b | 750 | ||
| NYHA I (no dypnea) | 66 | ||
| NYHA II | 26 | ||
| NYHA III-IV | 8 | ||
| Coronary artery disease c | |||
| No | 19 | ||
| Yes | 81 | ||
| Left ventricular ejection fraction unitd | 663 | 64.6 (12.0) | |
| HADS-anxiety | 632 | 5.5 (4.0) | |
| HADS-depression | 632 | 3.9 (3.3) | |
| Angina Frequency Scale (AFS) | 682 | 62.7 (28.5) | |
| Exertional Capacity Scale (ECS) | 698 | 66.2 (18.9) | |
| Social Function (SF) | 725 | 74.6 (25.1) | |
| General Health (GH) | 715 | 58.1 (19.4) | |
| Confrontive copinge | 549 | 1.44 (0.61) | |
| Normalising optimistic copinge | 582 | 2.17 (0.54) | |
| Combined emotive copinge | 590 | 0.89 (0.57) | |
| Perception of living with angina pectoris | 612 | 3.9 (1.4) | |
| Overall quality of life | 624 | 3.2 (1.3) | |
a Canadian Cardiovascular Society classification
b New York Heart Association
c Angiographic diameter stenosis of at least 50% in at least one of the main coronary arteries or their major side branches
d Left ventriculography was performed in 88% of the patients
e Alternative mean (SD) scores for coping using a 0–100 scale: Confrontive coping: 47.9 (20.4), Normalising optimistic: 72.4 (18.1) and Combined emotive coping: 29.5 (18.9).
Regression analyses for angina (Angina Frequency Scale), anxiety and depression (Hospital Anxiety and Depression Scale), functioning (Exertional Capacity Scale and Social Function), coping (Confrontive coping, Normalising Optimistic coping, Combined Emotive coping scales), perceived burden, general health and overall quality of life.
| CADq | -9.49;** | -0.36 | 0.47 | -0.50 | -1.13 | 0.42 | -0.49 | -0.16 | 0.16 | 1.74 | 0.08 |
| AFSa | 0.23; *** | 0.14; *** | -0.03 | -0.06;° | -0.02 | 0.02; *** | 0.03 | -0.00 | |||
| HADS-A b | -0.22 | -1.91; *** | 1.32; *** | 0.79; ** | 1.75; *** | -0.07; *** | -0.59;* | 0.06; *** | |||
| HADS-D c | -1.09; *** | -2.42; *** | -0.38 | -1.41; *** | 1.40; *** | -0.00 | -0.74; * | 0.06; ** | |||
| CCS j | *** | *** | |||||||||
| I vs. 0 | -3.16 | -0.04 | 1.99 | 0.89 | -0.56 | -0.37; ** | -2.23 | -0.19 | |||
| II vs. 0 | -2.48 | 3.36 | -0.72 | 0.08 | 0.88 | -0.55; *** | -2.77 | -0.21;° | |||
| III vs. 0 | -9.09; *** | 0.42 | -0.58 | 2.60 | 2.72 | -0.50; ** | -1.52 | -0.24 | |||
| NYHA k | *** | * | |||||||||
| II vs. 0–I | -3.55; ** | -1.16 | -0.40 | 0.95 | -0.41 | 0.16 | -1.70 | 0.08 | |||
| III-IV vs. 0–I | -8,01; *** | -8.17; *** | -2.40 | -3.64 | 1.44 | 0.11 | -4.75;° | 0.03 | |||
| ECSd | -0.07 | -0.12; * | -0,00 | 0.02; *** | 0.23; *** | 0.00 | |||||
| SF e | -0.05 | 0.01 | -0.11; *** | 0.00; * | 0.11; ** | -0.01; *** | |||||
| Cof | 0.01; * | 0.07;° | -0.01; * | ||||||||
| Nof | -0.01; ** | -0.03; | -0.00 | ||||||||
| Cef | -0.01° | -0.10;° | 0.01;° | ||||||||
| Burdeng | *** | ||||||||||
| 5 vs. 6 | -1.19 | -0.29 | |||||||||
| 4 vs. 6 | -0.07 | -0.52; ** | |||||||||
| 3 vs. 6 | 0.62 | -0.54; ** | |||||||||
| 2 vs. 6 | 2.56 | -0.64; ** | |||||||||
| 1 vs. 6 | 3.04 | -1.14; *** | |||||||||
| Adjusted R2 | 0.05 | 0.12 | 0.06 | 0.42 | 0.39 | 0.15 | 0.09 | 0.51 | 0.48 | 0.39 | 0.43 |
| Interactions t | 0.87 | 0.30 | 0.37 | 0.19 | 0.067 | 0.37 | 0.75 | 0.023 | 0.38 | 0.30 | 0.44 |
Analyses adjusted for gender, age, education, cohabitation, smoking, body mass index (BMI), diabetes and co morbidity. Regression coefficients; p-values are presented.
q CAD: Coronary artery disease vs no CAD (after angiography)
a AFS: Angina Frequency Scale (Seattle Angina Questionnaire), scale score 0 (worst) to 100 (best).
b HADS-A: Anxiety (Hospital Anxiety and Depression Scale), scale score 0 (best) to 21 (worst).
c HADS-D: Depression (Hospital Anxiety and Depression Scale), scale score 0 (best) to 21 (worst).
d ECS: Exertional Capacity Scale (Seattle Angina Questionnaire), scale scores 0 (worst) to 100 (best).
e SF: Social Function (SF-36), scale scores 0 (worst) to 100 (best).
f Co: Confrontive coping, No: Normalising Optimistic and Ce: Combined Emotive coping. The three dimensions in Wahl et al's model [33] of the Jalowiec Coping Scale [32]
g Burden: Perceived Burden- perception of living with angina pectoris, 1 (worst) to 6 (best).
h GH: General Health (SF-36), scale scores 0 (worst) to 100 (best).
i QOL: Overall quality of life, 1 (best) to 7 (worst).
j CCS: Canadian Cardiovascular Society Angina Classification, 0 (no angina) to IV (worst, not present in our data).
k NYHA: New York Hear Association Dyspnoea Classification, 0 (no dyspnoea) to IV (worst). 0 and I, and III and IV, collapsed in our data due to small numbers.
t All two-way interactions, overall p-value. Feasible after a few simplifications if necessary.
°p ≤ 0.10; * p ≤ .05. ** p ≤ .01. *** p ≤ .001
Ordinal logistic regression for angina pectoris (CCS) (proportional odds models), logistic regression for dyspnea (NYHA).
| CAD a | 2.98; *** | 0.42; *** | 2.40;° |
| LVEF b | ** | *** | |
| 30 vs. 20 | 1.56 | 0.49 | 0.61 |
| 50 vs. 40 | 1.52 | 0.51 | 0.64 |
| 70 vs. 60 | 1.02 | 1.12 | 1.10 |
| Interactions t | 0.56 | 0.89 | |
Odds ratios; p-values are presented.
a CAD: CAD vs no CAD (after angiography).
b LVEF: Left ventricular ejection fraction. Nonlinear relationships entered, differences for selected LVEF intervals are presented.
Significantly associated to CCS (**), and to NYHA (II-IV vs. 0–I, ***). Nonlinearity: Significant for NYHA (II-IV vs. 0–I, **).
c CCS: Canadian Cardiovascular Society Angina Classification, 0 (no angina) to IV (worst, not present in our data).
d NYHA: New York Hear Association Dyspnoea Classification, 0 (no dyspnoea) to IV (worst). 0 and I, and III and IV, collapsed in our data due to small numbers
t All two-way interactions, overall p-value. Not feasible for NYHA, feasible after a few simplifications if necessary
°p ≤ 0.10; * p ≤ .05. ** p ≤ .01. *** p ≤ .001
Figure 2A: Association between left ventricular ejection fraction and angina (Angina Frequency Scale). B: Association between left ventricular ejection fraction and depression (HADS).